JOURNAL ARTICLE

Giannis Antetokounmpo Takes Stake in Beckham's Health Firm IM8.

  • Published In: Bloomberg.com, 2026. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Williams, Randall 3 of 3

Abstract

The article focuses on Milwaukee Bucks star Giannis Antetokounmpo's equity investment in IM8, a nutritional supplement company co-founded by health-sciences firm Prenetics and former footballer David Beckham. Launched in December 2024, IM8 claims to have reached $100 million in annualized revenue within 11 months and aims to become a major global supplement brand in three to five years, supported by endorsements from athletes like tennis player Aryna Sabalenka and F1 driver Ollie Bearman. Antetokounmpo intends to contribute beyond his public image by engaging with the company on consumer perspectives. The article also notes Prenetics' recent strategic shift away from cryptocurrency investments to focus on IM8. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2026/04, pN.PAG
  • Document Type:Article
  • Subject Area:Sports and Leisure
  • Publication Date:2026
  • Accession Number:192728281
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.